Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal glucagon in children and adolescents with type 1 diabetes
2015-003252-40Phase 3
- Sponsor
- T1D Exchange
- Start
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of glucagon in diabetes mellitus type 1 (T1D) (2 arms), sponsored by T1D Exchange. Primary endpoint: PK/PD relationship of glucagon.
02
Drugs
glucagon
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2015-003252-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003252-40.